Melatonin as a Repurposed Drug for Melanoma Treatment
Melanoma is the most aggressive type of skin cancer, with a greater risk of metastasis and a higher prevalence and mortality rate. This cancer type has been demonstrated to develop resistance to the known treatment options such as conventional therapeutic agents and targeted therapy that are current...
Main Authors: | Rachana Pathipaka, Anita Thyagarajan, Ravi P. Sahu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/11/1/9 |
Similar Items
-
Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment
by: Zachary J. Thompson, et al.
Published: (2022-09-01) -
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019-06-01) -
Repurposing of Drug Candidates for Treatment of Skin Cancer
by: Hernán Cortés, et al.
Published: (2021-01-01) -
Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease
by: Alf Spitschak, et al.
Published: (2022-12-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)